Showing results (121-130 of 234) with videos related to
Sort By:
Pageof 24
The Journal of Urology|December 17, 2013
Satisfaction with information used to choose prostate cancer treatmentScott M Gilbert, Martin G Sanda, Rodney L Dunn, et al.International Journal of Radiation Oncology, Biology, Physics|December 25, 2015
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233Timur Mitin, Asha George, Anthony L Zietman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02Li-Yan Khor, Kyounghwa Bae, Rebecca Paulus, et al.The New England Journal of Medicine|July 15, 2011
Radiotherapy and short-term androgen deprivation for localized prostate cancerChristopher U Jones, Daniel Hunt, David G McGowan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 TrialsJan C Buckner, Karla V Ballman, John C Michalak, et al.Radiation Oncology (London, England)|July 10, 2013
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyWilliam C Jackson, Skyler B Johnson, Darren Li, et al.Urology|October 22, 2013
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective studyHiram Alberto Gay, Jeff M Michalski, Daniel A Hamstra, et al.International Journal of Radiation Oncology, Biology, Physics|November 13, 2020
Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the ProstateI-Chow Hsu, Joseph P Rodgers, Katsuto Shinohara, et al.Prostate Cancer|November 24, 2011
Prostate intrafraction translation margins for real-time monitoring and correction strategiesDale W Litzenberg, James M Balter, Scott W Hadley, et al.The Lancet. Oncology|September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trialLi-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.Pageof 24